| Swift Networks Group Limited (SW1) ORDINARY FULLY PAID |
Communication Services |
$11 |
Notification of Investor briefing
|
31 Jul 2025 12:02PM |
$0.009 |
$0.010 |
risen by
11.11%
|
|
| Swift Networks Group Limited (SW1) ORDINARY FULLY PAID |
Communication Services |
$11 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 12:00PM |
$0.009 |
$0.010 |
risen by
11.11%
|
|
SW1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly Activities Report and Appendix 4C Cash Flow Report released for the quarter ended 30 June 2023
- Continued focus on strategic transformation and business stabilization
- Growth in recurring revenue streams and new contract wins, particularly in the resources sector
- Improvements in customer retention and operational efficiency
- Disciplined cost control and cash management initiatives implemented
- Stronger balance sheet despite ongoing industry headwinds
- Initiatives underway to diversify revenue streams and optimize operating models
- Investment in technology and service innovation to support long-term growth
- Appendix 4C details cash flows and reaffirms commitment to prudent financial management
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cann Group Limited (CAN) ORDINARY FULLY PAID |
Health Care |
$7 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 11:59AM |
$0.014 |
$0.005 |
fallen by
67.86%
|
|
CAN - Price-sensitive ASX Announcement
Full Release
Key Points
- Cann Group Limited released its Quarterly Activities and Appendix 4C Cash Flow Report for the quarter ended 31 March 2024.
- The company reported cash receipts from customers of $4.7 million, an increase from the previous quarter.
- Cann Group completed a $10.2 million placement and share purchase plan to strengthen its balance sheet.
- Operational highlights include progress in medicinal cannabis production and continued commercial supply agreements.
- The Mildura facility maintained strong production and operational output, supporting domestic and international sales.
- Research and development activities continued, including pharmaceutical product development and expanded clinical programs.
- Net cash used in operating activities for the quarter was $3.9 million, reflecting ongoing investment in production and R&D.
- The company is pursuing additional cost-saving initiatives and efficiency improvements.
- Cash at the end of the quarter was $11.2 million, up from $5.1 million at the end of December 2023.
- No payments were made to related parties or their associates except for remuneration as disclosed.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tasman Resources Limited (TAS) ORDINARY FULLY PAID |
Materials |
$25 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 11:59AM |
$0.015 |
$0.046 |
risen by
206.67%
|
|
TAS - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly report covers operations for the March 2023 quarter.
- Exploration activities focused on the Lake Torrens Project.
- No significant exploration activities at other projects during the quarter.
- Administrative and corporate developments are summarized.
- Cash flow report (Appendix 5B) outlines receipts, payments, and movements in cash.
- Expenditure mainly related to exploration and evaluation activities.
- The company ended the quarter with a cash balance of approximately $1.8 million.
- No substantial financing or investing cash flows reported during the quarter.
- Tasman Resources remains committed to maintaining exploration and partnership agreements.
- Future plans include ongoing monitoring of expenditure and seeking further opportunities.
- The report confirms compliance with ASX Listing Rules.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tissue Repair Ltd (TRP) ORDINARY FULLY PAID |
Health Care |
$7 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 11:57AM |
$0.240 |
$0.110 |
fallen by
54.17%
|
|
TRP - Price-sensitive ASX Announcement
Full Release
Key Points
- Completed patient enrollment for Phase III SURF1 clinical trial of TR-987 for chronic wounds
- Ongoing regulatory interactions with relevant authorities for approvals and guidance
- Preparation for top-line data readout from SURF1 study expected in Q2 2024
- Operating cash outflows primarily related to research and development activities
- TRP maintains adequate cash reserves to support planned clinical and operational activities
- Business development efforts continue, including potential partnerships and strategic collaborations
- Declared compliance with ASX Listing Rule 4.7C regarding use of funds
- Forward-looking statements made concerning future milestones and commercialization plans
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clarity Pharmaceuticals Ltd (CU6) ORDINARY FULLY PAID |
Health Care |
$899 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 11:57AM |
$4.435 |
$2.410 |
fallen by
45.66%
|
|
CU6 - Price-sensitive ASX Announcement
Full Release
Key Points
- Clarity Pharmaceuticals Ltd provided its quarterly activities report and Appendix 4C cash flow report for the quarter ending 31 March 2024.
- The company is advancing clinical trials for its lead product, SAR-bisPSMA (Targeted Copper Theranostic), in the diagnosis and treatment of prostate cancer.
- Key studies mentioned include the CLARIFY Phase III, COBRA Phase II, and SECURE Phase II trials, with progress updates for each.
- Recruitment for patient cohorts in these studies is progressing, with several milestones achieved including near completion of the SECURE dose escalation cohort.
- Clarity has received guidance from the US FDA for the path to potential New Drug Application (NDA) submission for SAR-bisPSMA.
- The company continues to expand its pipeline with additional programs such as SARTATE for neuroblastoma and NETs.
- Financially, the company maintains a strong position with $75.1 million in cash at the end of the quarter.
- Net operating outflows for the quarter were $8.1 million, primarily comprising research and development expenses.
- Clarity does not anticipate the need to raise additional capital in the near term.
- The report provides a detailed summary of cash flows and operational expenses as per the Appendix 4C requirements.
- Strategic partnerships, manufacturing advancements, and regulatory interactions are highlighted as supporting ongoing and future clinical programs.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cadoux Limited (CCM) ORDINARY FULLY PAID |
Materials |
$11 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 11:56AM |
$0.030 |
$0.024 |
fallen by
20%
|
|
CCM - Price-sensitive ASX Announcement
Full Release
Key Points
- Cadoux’s primary focus in the quarter was advancing the high-purity alumina (HPA) project through its Critical Minerals Group (CCM) joint venture subsidiary.
- Progress was made in engineering studies and HPA project feasibility.
- Discussions with potential offtake partners, financiers, and project partners continued.
- Cash flow report (Appendix 5B) provided, highlighting expenditure on project development and corporate costs.
- The company ended the quarter with $1.36 million in cash and continues to seek additional funding.
- Corporate updates included continued compliance with statutory and ASX requirements.
- Key project milestones for the coming quarters were outlined, focusing on project advancement and funding.
- No significant production or sales were reported for the period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tempest Minerals Limited (TEM) ORDINARY FULLY PAID |
Materials |
$4 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 11:56AM |
$0.006 |
$0.004 |
fallen by
33.33%
|
|
TEM - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly Activities and Cash Flow Report released for period ending 30 September 2023.
- Diamond drilling commenced at Remorse Target within the Meleya Project.
- Messenger Project drilling completed as part of ongoing exploration activities.
- Geochemical soil sampling and regional exploration activities advanced in Yalgoo region.
- Net cash outflows for exploration, administration, and staffing costs.
- Closing cash balance of $0.84 million as of 30 September 2023.
- Directors and related parties received modest payments for services during the quarter.
- No significant exploration activities occurred at Euro and War West projects during the period.
- Company continues to review new project opportunities and maintain a disciplined approach to expenditure.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Fin Resources Limited (FIN) |
Materials |
$7 |
Quarterly Activities Report & Appendix 5B
|
31 Jul 2025 11:54AM |
$0.004 |
$0.005 |
risen by
25%
|
|
FIN - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarter ended 30 June 2023 covered.
- Focus on exploration projects in Quebec, Canada.
- Geophysical, geological, and drilling planning activities advanced.
- Progress on other Canadian exploration assets noted.
- Strong cash position and careful cost management.
- No material revenue generated as the company remains in exploration phase.
- Appendix 5B details cash flows and financials.
- Summary of tenement holdings included.
- Compliance and corporate governance statements provided.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Delorean Corporation Limited (DEL) ORDINARY FULLY PAID |
Utilities |
$25 |
Q4 FY25 Quarterly Activities Report
|
31 Jul 2025 11:54AM |
$0.170 |
$0.100 |
fallen by
41.18%
|
|
DEL - Price-sensitive ASX Announcement
Full Release
Key Points
- Discusses operational performance and achievements for the quarter.
- Provides updates on major bioenergy projects, including construction progress and commissioning.
- Highlights revenue generation, cash flow status, and capital management activities.
- Addresses challenges such as market fluctuations and regulatory impacts.
- Emphasizes strategic focus on project pipeline expansion and new business opportunities.
- Details collaboration with stakeholders and pursuit of sustainability objectives.
- Mentions ongoing efforts to enhance shareholder value through growth and innovation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Audio Pixel Holdings Limited (AKP) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 11:53AM |
$6.200 |
$6.200 |
fallen by
0%
|
|
| EQ Resources Limited (EQR) ORDINARY FULLY PAID |
Materials |
$1,406 |
Quarterly Activities/Appendix 5B Cash Flow Report-June 2025
|
31 Jul 2025 11:53AM |
$0.034 |
$0.275 |
risen by
708.82%
|
|
EQR - Price-sensitive ASX Announcement
Full Release
Key Points
- Mt Carbine Tungsten Mine achieved record production and sales during the quarter.
- Commissioning of upgraded ore sorting and processing facilities progressed as planned.
- Strong demand and favorable pricing for tungsten concentrate supported sales growth.
- Open pit expansion activities advanced, with stripping and pre-production activities on target.
- Operational improvements yielded increased recovery rates and cost efficiencies.
- Significant investment secured through capital raising and grant funding.
- Ongoing exploration and resource definition drilling continued at Mt Carbine.
- ESG initiatives, including community and environmental programs, were implemented.
- Cash flow from operations improved compared to previous quarters.
- Company remains well positioned for further growth and expansion in the upcoming quarters.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Red Metal Limited (RDM) ORDINARY FULLY PAID |
Materials |
$58 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 11:52AM |
$0.125 |
$0.150 |
risen by
20%
|
|
RDM - Price-sensitive ASX Announcement
Full Release
Key Points
- Red Metal Limited (ASX: RDM) reported its Quarterly Activities and Cash Flow for the period ending 31 March 2024.
- Exploration focused on the Corkwood, Nullarbor, and Three Ways projects, with drilling planned for copper, nickel, and critical mineral targets.
- At Corkwood, Red Metal is finalizing plans for drilling several high-priority copper targets during the 2024 field season.
- The company advanced pre-drill work at the Nullarbor project, targeting nickel-copper sulphide and uranium mineralization.
- Geophysical and geochemical programs continued at Three Ways to define copper and base metals targets.
- Red Metal maintains a strong cash position with approximately $3.94 million at the end of the quarter.
- The company is funded for its planned exploration programs and does not anticipate requiring additional capital in the short term.
- No mining production or sales occurred during the quarter; activities centered on exploration and project evaluation.
- Expenditures for exploration and evaluation during the quarter totaled $512,000.
- Red Metal is optimistic about the potential for major mineral discoveries at its key project sites.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Eden Innovations Ltd (EDE) ORDINARY FULLY PAID |
Energy |
$73 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 11:52AM |
$0.002 |
$0.120 |
risen by
7,900%
|
|
EDE - Price-sensitive ASX Announcement
Full Release
Key Points
- Eden Innovations Ltd released its Quarterly Activities Report for Q1 2024.
- The main focus remains on EdenCrete® product sales and market expansion.
- Progress made in US infrastructure projects and commercial trials.
- Ongoing efforts to secure further approvals and certifications for EdenCrete®.
- Sales and business development initiatives continued in the US, Europe, and Australia.
- Financial report details cash receipts, outflows, and closing cash position as at 31 March 2024.
- Updates provided on research and development and intellectual property status.
- Report includes all relevant regulatory disclosures and material business events for the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Bond Exchange Holdings Limited (ABE) ORDINARY FULLY PAID |
Financials |
$2 |
Director Form 3Y
|
31 Jul 2025 11:49AM |
$0.034 |
$0.012 |
fallen by
64.71%
|
|
| Australian Bond Exchange Holdings Limited (ABE) ORDINARY FULLY PAID |
Financials |
$2 |
Director Form 3Y
|
31 Jul 2025 11:48AM |
$0.034 |
$0.012 |
fallen by
64.71%
|
|
| Liontown Limited (LTR) ORDINARY FULLY PAID |
Materials |
$4,737 |
Presentation - Kathleen Valley Site Tour
|
31 Jul 2025 11:48AM |
$0.788 |
$1.490 |
risen by
89.21%
|
|
| Jameson Resources Limited (JAL) ORDINARY FULLY PAID |
Materials |
$36 |
JAL EGM 31 July 2025 - Results of Meeting
|
31 Jul 2025 11:47AM |
$0.085 |
$0.045 |
fallen by
47.06%
|
|
| ikeGPS Group Limited (IKE) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Information Technology |
$193 |
Application for quotation of securities - IKE
|
31 Jul 2025 11:45AM |
$0.900 |
$0.990 |
risen by
10%
|
|
| Freehill Mining Limited (FHS) ORDINARY FULLY PAID |
Materials |
$8 |
Quarterly Activities Report
|
31 Jul 2025 11:44AM |
$0.005 |
$0.002 |
fallen by
55.56%
|
|
FHS - Price-sensitive ASX Announcement
Full Release
Key Points
- Freehill Mining Limited continued magnetite concentrate production and sales from its Chilean operations.
- The Yerbas Buenas Project progressed with ongoing geological and metallurgical studies.
- The Lara Project saw further development with exploration and assessment activities.
- Corporate updates included changes to the board of directors and executive management.
- The company discussed its funding position and future financing strategies.
- Financial statements for the quarter were presented, outlining income and expenditure.
- Market conditions and the outlook for iron ore and related commodities were analyzed.
- Planned exploration and development activities for the next quarter were detailed.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Freehill Mining Limited (FHS) ORDINARY FULLY PAID |
Materials |
$8 |
Quarterly Appendix 5B Cash Flow Report
|
31 Jul 2025 11:43AM |
$0.005 |
$0.002 |
fallen by
55.56%
|
|
FHS - Price-sensitive ASX Announcement
Full Release
Key Points
- Freehill Mining Limited released its Appendix 5B cash flow report for the quarter ending 31 December 2023.
- The report lists detailed cash flows including receipts from customers and payments for exploration, staff, administration, and corporate costs.
- Net cash used in operating activities is outlined, along with any investing and financing cash flows.
- The document provides the quarter-end cash balance and projects estimated future cash outflows.
- Related party transactions, including payments to directors and associates, are disclosed.
- The report is prepared in accordance with ASX Listing Rule requirements and includes relevant certifications and sign-off by a company director or authorized officer.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Auric Mining Limited (AWJ) ORDINARY FULLY PAID |
Materials |
$45 |
Quarterly Activities Report
|
31 Jul 2025 11:42AM |
$0.170 |
$0.240 |
risen by
41.18%
|
|
AWJ - Price-sensitive ASX Announcement
Full Release
Key Points
- Completed Stage One mining at Jeffreys Find Gold Mine with 9,741 ounces of gold produced and sold.
- Gold sales for the quarter totaled $29.28 million, with all mining and milling costs paid.
- Auric Mining's share of profits from Stage One was $4.4 million, contributing to a cash balance of $6.146 million as of 31 March 2024.
- Preparations for Stage Two mining at Jeffreys Find are progressing, aiming to commence in June 2024.
- Feasibility work and permitting are ongoing for further operations at Jeffreys Find.
- Exploration activities continued at Auric’s other wholly owned projects in Western Australia, including Munda and Spargoville.
- The company maintains a strong financial position, enabling future project development and exploration.
- Board and management updates, as well as compliance disclosures, are included in the report.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PLS Group Limited (PLS) ORDINARY FULLY PAID |
Materials |
$14,925 |
Notification of cessation of securities - PLS
|
31 Jul 2025 11:42AM |
$1.623 |
$4.630 |
risen by
185.36%
|
|
| PLS Group Limited (PLS) ORDINARY FULLY PAID |
Materials |
$14,925 |
Notification regarding unquoted securities - PLS
|
31 Jul 2025 11:40AM |
$1.623 |
$4.630 |
risen by
185.36%
|
|
| Spartan Resources Limited (SPR) ORDINARY FULLY PAID |
Materials |
- |
RMS: Ramelius completes acquisition of Spartan Resources
|
31 Jul 2025 11:40AM |
$2.130 |
$2.130 |
fallen by
0%
|
|
Call 1300 880 160
Start a chat
Schedule a call
